XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue
Expenses:    
Research and development 1,617
Selling, general and administrative 52,680 36,244
Total expenses 52,680 37,861
Loss from operations (52,680) (37,861)
Other income (expense)    
Interest income (expense)
Net loss $ (52,680) $ (37,861)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ 0
Weighted-average number of common shares outstanding - basic and diluted (in shares) 45,572,568 45,572,568